US Stock MarketDetailed Quotes

NKPH NIKA PHARMACEUTICALS INC

Watchlist
  • 0.700
  • 0.0000.00%
15min DelayClose Apr 24 16:00 ET
756.21MMarket Cap0.00P/E (TTM)

NIKA PHARMACEUTICALS INC Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-97.96%64.83K
-99.12%27.81K
209.85%19.57K
21,540.26%3.18M
356.06%15.05K
134.86%6.34K
106,557.99%3.16M
9.77%6.32K
65.17%14.71K
-62.27%3.3K
Selling and administrative expenses
-64.71%64.83K
-82.18%27.81K
209.85%19.57K
1,148.74%183.72K
356.06%15.05K
134.86%6.34K
5,172.39%156.01K
9.77%6.32K
65.17%14.71K
-62.27%3.3K
-General and administrative expense
-64.71%64.83K
-82.18%27.81K
209.85%19.57K
1,148.74%183.72K
356.06%15.05K
134.86%6.34K
5,172.39%156.01K
9.77%6.32K
65.17%14.71K
-62.27%3.3K
Research and development costs
--0
--0
----
--3M
--0
--0
--3M
----
--0
--0
Operating profit
97.96%-64.83K
99.12%-27.81K
-209.85%-19.57K
-21,540.26%-3.18M
-356.06%-15.05K
-134.86%-6.34K
-106,557.99%-3.16M
-9.77%-6.32K
-65.17%-14.71K
62.27%-3.3K
Net non-operating interest income expense
Other net income (expense)
Income before tax
97.96%-64.83K
99.12%-27.81K
-209.85%-19.57K
-21,540.26%-3.18M
-356.06%-15.05K
-134.86%-6.34K
-106,557.99%-3.16M
-9.77%-6.32K
-65.17%-14.71K
62.27%-3.3K
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
97.96%-64.83K
99.12%-27.81K
-209.85%-19.57K
-21,540.26%-3.18M
-356.06%-15.05K
-134.86%-6.34K
-106,557.99%-3.16M
-9.77%-6.32K
-65.17%-14.71K
62.27%-3.3K
Net income continuous Operations
97.96%-64.83K
99.12%-27.81K
-209.85%-19.57K
-21,540.26%-3.18M
-356.06%-15.05K
-134.86%-6.34K
-106,557.99%-3.16M
-9.77%-6.32K
-65.17%-14.71K
62.27%-3.3K
Minority interest income
Net income attributable to the parent company
97.96%-64.83K
99.12%-27.81K
-209.85%-19.57K
-21,540.26%-3.18M
-356.06%-15.05K
-134.86%-6.34K
-106,557.99%-3.16M
-9.77%-6.32K
-65.17%-14.71K
62.27%-3.3K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
97.96%-64.83K
99.12%-27.81K
-209.85%-19.57K
-21,540.26%-3.18M
-356.06%-15.05K
-134.86%-6.34K
-106,557.99%-3.16M
-9.77%-6.32K
-65.17%-14.71K
62.27%-3.3K
Basic earnings per share
97.96%-0.0001
99.11%-0
-214.29%-0
-21,276.47%-0.0036
-325.00%-0
-133.33%-0
-119,966.67%-0.0036
0.00%-0
-70.00%-0
60.00%-0
Diluted earnings per share
97.96%-0.0001
99.11%-0
-214.29%-0
-21,276.47%-0.0036
-325.00%-0
-133.33%-0
-119,966.67%-0.0036
0.00%-0
-70.00%-0
60.00%-0
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -97.96%64.83K-99.12%27.81K209.85%19.57K21,540.26%3.18M356.06%15.05K134.86%6.34K106,557.99%3.16M9.77%6.32K65.17%14.71K-62.27%3.3K
Selling and administrative expenses -64.71%64.83K-82.18%27.81K209.85%19.57K1,148.74%183.72K356.06%15.05K134.86%6.34K5,172.39%156.01K9.77%6.32K65.17%14.71K-62.27%3.3K
-General and administrative expense -64.71%64.83K-82.18%27.81K209.85%19.57K1,148.74%183.72K356.06%15.05K134.86%6.34K5,172.39%156.01K9.77%6.32K65.17%14.71K-62.27%3.3K
Research and development costs --0--0------3M--0--0--3M------0--0
Operating profit 97.96%-64.83K99.12%-27.81K-209.85%-19.57K-21,540.26%-3.18M-356.06%-15.05K-134.86%-6.34K-106,557.99%-3.16M-9.77%-6.32K-65.17%-14.71K62.27%-3.3K
Net non-operating interest income expense
Other net income (expense)
Income before tax 97.96%-64.83K99.12%-27.81K-209.85%-19.57K-21,540.26%-3.18M-356.06%-15.05K-134.86%-6.34K-106,557.99%-3.16M-9.77%-6.32K-65.17%-14.71K62.27%-3.3K
Income tax 0000000000
Net income 97.96%-64.83K99.12%-27.81K-209.85%-19.57K-21,540.26%-3.18M-356.06%-15.05K-134.86%-6.34K-106,557.99%-3.16M-9.77%-6.32K-65.17%-14.71K62.27%-3.3K
Net income continuous Operations 97.96%-64.83K99.12%-27.81K-209.85%-19.57K-21,540.26%-3.18M-356.06%-15.05K-134.86%-6.34K-106,557.99%-3.16M-9.77%-6.32K-65.17%-14.71K62.27%-3.3K
Minority interest income
Net income attributable to the parent company 97.96%-64.83K99.12%-27.81K-209.85%-19.57K-21,540.26%-3.18M-356.06%-15.05K-134.86%-6.34K-106,557.99%-3.16M-9.77%-6.32K-65.17%-14.71K62.27%-3.3K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 97.96%-64.83K99.12%-27.81K-209.85%-19.57K-21,540.26%-3.18M-356.06%-15.05K-134.86%-6.34K-106,557.99%-3.16M-9.77%-6.32K-65.17%-14.71K62.27%-3.3K
Basic earnings per share 97.96%-0.000199.11%-0-214.29%-0-21,276.47%-0.0036-325.00%-0-133.33%-0-119,966.67%-0.00360.00%-0-70.00%-060.00%-0
Diluted earnings per share 97.96%-0.000199.11%-0-214.29%-0-21,276.47%-0.0036-325.00%-0-133.33%-0-119,966.67%-0.00360.00%-0-70.00%-060.00%-0
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes------------------
Heat List
US
Overall
Symbol
Price
% Chg

No Data